The short answer
Oral aloe leaf gel may lower glucose when added to diabetes treatment, but the available trial does not prove that aloe with metformin alone causes hypoglycemia. The participants also took glyburide, and no adverse effects were reported. Review the exact aloe product and all glucose-lowering medicines before adding it.
What this answer covers
Metformin with an oral Aloe vera leaf-gel preparation; topical aloe, latex and other leaf extracts are outside the directly studied preparation.
- Supplement or preparation
- Aloe vera
- Medication ingredient
- metformin
What was actually studied?
Sixty adults with poorly controlled type 2 diabetes and abnormal blood lipids received aloe leaf gel or placebo for two months. They continued metformin 1,000 mg/day and glyburide 10 mg/day. Aloe was given as 300 mg capsules twice daily. Glucose and HbA1c improved more with aloe, but this specific regimen is different from aloe with metformin alone.
Does lower glucose mean dangerous low glucose?
A reduction from high glucose toward a target is not the same outcome as hypoglycemia. The original study abstract reports no adverse effects, without providing detailed low-glucose event counts or how episodes were sought. That limits both a strong harm claim and a declaration that the combination is safe for everyone.
Which details change the concern?
Metformin by itself rarely causes hypoglycemia, while insulin and medicines such as glyburide increase the concern. Missed food intake and alcohol also matter. An oral leaf-gel capsule cannot stand in for every aloe drink, concentrated botanical extract or topical product. Bring the ingredient panel and your complete diabetes regimen to the pharmacist.
Can I solve this by separating the doses?
The trial did not establish a number of hours that prevents an additive glucose effect. Discuss whether aloe is useful for your situation and whether your existing glucose-monitoring plan needs adjustment. Do not reduce prescribed diabetes treatment to make room for aloe; the evidence is too limited to predict an individual response.
Evidence and practical considerations
Side effects & toxicity
Oral aloe leaf gel may lower glucose when added to diabetes treatment, but the available trial does not prove that aloe with metformin alone causes hypoglycemia. The participants also took glyburide, and no adverse effects were reported. Review the exact aloe product and all glucose-lowering medicines before adding it.
- Exact scope
- oral Aloe vera leaf gel, 300 mg twice daily in the direct multidrug trial with oral metformin; hydrochloride IR, ER or low-dose solution retained source by source
- Medication form and route
- oral
- Timing or duration
- Two-month supplementation trial; no validated same-day spacing rule.
What remains uncertain
- A multidrug trial supports additional glucose lowering but does not isolate metformin or establish symptomatic hypoglycemia risk.
Factors that may matter: exact preparation and dose; medication formulation and duration; other medicines and underlying conditions; source population and measured outcome.
Read the supporting source summaries
Source 1: regulatory product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Adults receiving oral extended-release metformin hydrochloride.
Advises annual hematologic assessment and B12 measurements every 2-3 years. Hypoglycemia is uncommon with metformin alone but risk is greater with insulin or secretagogues and other circumstances.
How this applies: Exact metformin parent RxCUI 6809 with hydrochloride formulation retained. Monitoring and general precautions only unless B12 is the counterparty. Counterparty scope for this package: oral Aloe vera leaf gel, 300 mg twice daily in the direct multidrug trial.
Extended-release label is not a study of immediate-release interaction kinetics; no aloe, chromium or goldenseal-specific effect or interval quantified.
Source 2: original randomized controlled trial
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 60 adults aged 40-60 with dyslipidemic type 2 diabetes despite metformin and glyburide, randomized 30 per group.
Fasting glucose and HbA1c improved versus placebo; authors reported no adverse effects.
How this applies: Direct co-use with metformin in a multidrug regimen and one oral leaf-gel preparation; not latex, topical aloe, or every extract. Counterparty scope for this package: oral Aloe vera leaf gel, 300 mg twice daily in the direct multidrug trial.
Abstract-only; no detailed hypoglycemia ascertainment or event counts. Glyburide co-treatment prevents isolating metformin-only risk. Glucose improvement is not itself hypoglycemia.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Original evidence and current labels checked; complete private article and exact-current-claim adjudications prepared. | |
| Research summary published |
Article revision: 31794ea8fa589406
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.